Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Azimilide-d8 (dihydrochloride)

Azimilide-d8 (NE-10064-d8) dihydrochloride is the deuterium labeled Azimilide dihydrochloride. Azimilide dihydrochloride is a class III antiarrhythmic agent, which works by blocking potassium channels in the heart. Azimilide dihydrochloride is a dual blocker of IKs (IC50 = 2.6 μM (2mM [K⁺]ₑ) ) and IKr (IC50 = 1 μM (4 mM [K⁺]) ). Azimilide dihydrochloride blocked HERG channel at 0.1 and 1 Hz with IC50s of 1.4 μM and 5.2 μM respectively. Azimilide dihydrochloride also inhibits L-type calcium current (ICa) (IC50 = 17.8 μM) and sodium current (INa) (IC50 = 19 μM). Azimilide dihydrochloride can be used for the study of atrial fibrillation and ventricular fibrillation[1][2][3][4].

Product Specifications

Product Name Alternative

NE-10064-d8 (dihydrochloride)

UNSPSC

12352005

Target

Calcium Channel; Isotope-Labeled Compounds; Potassium Channel; Sodium Channel

Type

Isotope-Labeled Compounds

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling; Others

Field of Research

Cardiovascular Disease

Solubility

10 mM in DMSO

Smiles

O=C1N(/N=C/C2=CC=C(O2)C3=CC=C(C=C3)Cl)CC(N1CCCCN4C([2H])(C([2H])(N(C)C([2H])(C4([2H])[2H])[2H])[2H])[2H])=O.[2HCl]

Molecular Formula

C23H22D8Cl3N5O3

Molecular Weight

538.92

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Busch AE, et al. Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action. Br J Pharmacol. 1998 Jan;123 (1) :23-30.|[3]Yao JA, et al. Azimilide (NE-10064) can prolong or shorten the action potential duration in canine ventricular myocytes: dependence on blockade of K, Ca, and Na channels. J Cardiovasc Electrophysiol. 1997 Feb;8 (2) :184-98.|[4]Fermini B, et al. Use-dependent effects of the class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: block of delayed rectifier potassium and L-type calcium currents. J Cardiovasc Pharmacol. 1995 Aug;26 (2) :259-71.|[5]Black SC, et al. Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug. J Cardiovasc Pharmacol. 1993 Dec;22 (6) :810-8.

Shipping Conditions

Room temperature

Scientific Category

Isotope-Labeled Compounds

Clinical Information

No Development Reported

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

C1orf38 (THEMIS2) Human Gene Knockout Kit (CRISPR)
KN419127 1 Kit

C1orf38 (THEMIS2) Human Gene Knockout Kit (CRISPR)

Sign In for Pricing
View Details
VEGF-R2 / CD309 / Flk-1 / KDR3 (DC101), CF740 conjugate, 0.1mg/mL
BNC740531-100 1x 100 µL

VEGF-R2 / CD309 / Flk-1 / KDR3 (DC101), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
DDAH1 Rabbit Polyclonal Antibody
TA384087 100 µL

DDAH1 Rabbit Polyclonal Antibody

Sign In for Pricing
View Details
Sarcomeric Actinin Alpha 2 / ACTN2 (ACTN2/3293), CF740 conjugate, 0.1mg/mL
BNC743293-100 1x 100 µL

Sarcomeric Actinin Alpha 2 / ACTN2 (ACTN2/3293), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
RFC2 (NM_002914) Human Over-expression Lysate
LY419017 100 µg

RFC2 (NM_002914) Human Over-expression Lysate

Sign In for Pricing
View Details
Desfluoro Pibrentasvir Impurity
TRC-D720890-10MG 10 mg

Desfluoro Pibrentasvir Impurity

Sign In for Pricing
View Details